Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDYD Bio Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/29/2025 | Q2 2025 | N/A | -$0.65 | N/A | N/A | $0 |
| 03/30/2025 | Q1 2025 | N/A | -$0.98 | N/A | N/A | $0 |
| 12/30/2024 | Q4 2024 | N/A | $0.10 | N/A | N/A | $0 |
| 09/29/2024 | Q3 2024 | N/A | $0.54 | N/A | N/A | $0 |
| 06/29/2024 | Q2 2024 | N/A | $4.05 | N/A | N/A | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$5.12 | N/A | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | $0.16 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
YD Bio Ltd. Earnings: FAQ's
The conference call for YD Bio Ltd.'s latest earnings report can be listened to online.
The conference call transcript for YD Bio Ltd.'s latest earnings report can be read online.
YD Bio Ltd. (:YDES) has a recorded annual revenue of $596.82 K.
YD Bio Ltd. (:YDES) has a recorded net income of $-8,311,316.YD Bio Ltd. has generated $-0.12 earnings per share over the last four quarters.
YD Bio Ltd. (:YDES) has a price-to-earnings ratio of -3.43 and price/earnings-to-growth ratio is 0.01.